These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35341572)

  • 21. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT
    De Gregorio D; Posa L; Ochoa-Sanchez R; McLaughlin R; Maione S; Comai S; Gobbi G
    Pharmacol Res; 2016 Nov; 113(Pt A):81-91. PubMed ID: 27544651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference.
    Grandy DK; Miller GM; Li JX
    Drug Alcohol Depend; 2016 Feb; 159():9-16. PubMed ID: 26644139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2.
    Shi X; Swanson TL; Miner NB; Eshleman AJ; Janowsky A
    Mol Pharmacol; 2019 Oct; 96(4):493-504. PubMed ID: 31409621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
    Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
    Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1.
    Espinoza S; Ghisi V; Emanuele M; Leo D; Sukhanov I; Sotnikova TD; Chieregatti E; Gainetdinov RR
    Neuropharmacology; 2015 Jun; 93():308-13. PubMed ID: 25721394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor.
    Espinoza S; Salahpour A; Masri B; Sotnikova TD; Messa M; Barak LS; Caron MG; Gainetdinov RR
    Mol Pharmacol; 2011 Sep; 80(3):416-25. PubMed ID: 21670104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1.
    Achat-Mendes C; Lynch LJ; Sullivan KA; Vallender EJ; Miller GM
    Pharmacol Biochem Behav; 2012 Apr; 101(2):201-7. PubMed ID: 22079347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
    Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P
    J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review.
    Alnefeesi Y; Tamura JK; Lui LMW; Jawad MY; Ceban F; Ling S; Nasri F; Rosenblat JD; McIntyre RS
    Neurosci Biobehav Rev; 2021 Dec; 131():192-210. PubMed ID: 34537265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain.
    Xie Z; Miller GM
    J Pharmacol Exp Ther; 2009 Jul; 330(1):316-25. PubMed ID: 19364908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research progress on the immunomodulatory effects and mechanisms of trace amine-associated receptor 1].
    Zhang XQ; Li JT; Si TM; Su YA
    Sheng Li Xue Bao; 2023 Apr; 75(2):248-254. PubMed ID: 37089099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of trace amine-associated receptor 1 (TAAR1) transiently reduces alcohol drinking in socially housed mice.
    Frycz BA; Nowicka K; Konopka A; Hoener MC; Bulska E; Kaczmarek L; Stefaniuk M
    Addict Biol; 2023 Jul; 28(7):e13285. PubMed ID: 37369127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vivo pharmacology of Trace-Amine Associated Receptor 1.
    Lam VM; Espinoza S; Gerasimov AS; Gainetdinov RR; Salahpour A
    Eur J Pharmacol; 2015 Sep; 763(Pt B):136-42. PubMed ID: 26093041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research progress of trace amine-associated receptor 1 signaling pathways].
    Sun M; Zhang CC; Li JT; Si TM; Su YA
    Sheng Li Xue Bao; 2024 Feb; 76(1):89-96. PubMed ID: 38444134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a trace amine-associated receptor 1 agonist RO 5263397 on ethanol-induced behavioral sensitization.
    Wu R; Liu J; Wang K; Huang Y; Zhang Y; Li JX
    Behav Brain Res; 2020 Jul; 390():112641. PubMed ID: 32407821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trace amine-associated receptor 1 as a monoaminergic modulator in brain.
    Xie Z; Miller GM
    Biochem Pharmacol; 2009 Nov; 78(9):1095-104. PubMed ID: 19482011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats.
    Grinchii D; Hoener MC; Khoury T; Dekhtiarenko R; Nejati Bervanlou R; Jezova D; Dremencov E
    Mol Psychiatry; 2022 Dec; 27(12):4861-4868. PubMed ID: 36045279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reward and aversion in a heterogeneous midbrain dopamine system.
    Lammel S; Lim BK; Malenka RC
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):351-9. PubMed ID: 23578393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
    Pei Y; Asif-Malik A; Canales JJ
    Front Neurosci; 2016; 10():148. PubMed ID: 27092049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.